Per Norlén
CEO
Clinical pharmacology
Alligator Bioscience AB
Sweden
Biography
Per Norlén - born 1970, CEO since 2015, Medical Chief (CMO) since 2010 - is a registered doctor with doctorate and specialist physician in clinical pharmacology and lecturer in experimental and clinical pharmacology at Lund University. Per Norlén has 25 years of experience in pharmacology research, including 14 years of clinical drug development experience focusing on clinical Phase I / II studies. Member of the management since 2010.
Research Interest
Clinical drug development
